A YAP/TAZ-ARHGAP29-RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin Adhesions

  • Manuel Rogg
  • Jasmin I Maier
  • Martin Helmstädter
  • Alena Sammarco
  • Felix Kliewe
  • Oliver Kretz
  • Lisa Weißer
  • Clara Van Wymersch
  • Karla Findeisen
  • Anna L Koessinger
  • Olga Tsoy
  • Jan Baumbach
  • Markus Grabbert
  • Martin Werner
  • Tobias B Huber
  • Nicole Endlich
  • Oliver Schilling
  • Christoph Schell

Related Research units


Glomerular disease due to podocyte malfunction is a major factor in the pathogenesis of chronic kidney disease. Identification of podocyte-specific signaling pathways is therefore a prerequisite to characterizing relevant disease pathways and developing novel treatment approaches. Here, we employed loss of function studies for EPB41L5 (Yurt) as a central podocyte gene to generate a cell type-specific disease model. Loss of Yurt in fly nephrocytes caused protein uptake and slit diaphragm defects. Transcriptomic and proteomic analysis of human EPB41L5 knockout podocytes demonstrated impaired mechanotransduction via the YAP/TAZ signaling pathway. Further analysis of specific inhibition of the YAP/TAZ-TEAD transcription factor complex by TEADi led to the identification of ARGHAP29 as an EPB41L5 and YAP/TAZ-dependently expressed podocyte RhoGAP. Knockdown of ARHGAP29 caused increased RhoA activation, defective lamellipodia formation, and increased maturation of integrin adhesion complexes, explaining similar phenotypes caused by loss of EPB41L5 and TEADi expression in podocytes. Detection of increased levels of ARHGAP29 in early disease stages of human glomerular disease implies a novel negative feedback loop for mechanotransductive RhoA-YAP/TAZ signaling in podocyte physiology and disease.

Bibliographical data

Original languageEnglish
Article number1795
Publication statusPublished - 06.07.2023
PubMed 37443829